香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Fortune Sun (China) Holdings Limited 富陽（中國）控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：00352） 有關復牌進度的季度最新消息及 繼續暫停買賣 本 公 告 乃 由 富 陽（中 國）控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」） 根 據 香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）證 券 上 市 規 則（「上市規則」）第13.09條 以及香港法例第571章《證 券 及 期 貨 條 例》第XIVA部 項 下 的 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 茲提述本公司(i)日 期 為 二 零 二 五 年 九 月 九 日 之 公 告，內 容 有 關（其 中 包 括）上 市 委 員 會 決 定 維 持 上 市 科 所 作 出 之 ...

Core Viewpoint - *ST Zhengping has announced that its stock will resume trading on December 3, 2025, after completing a review of its trading situation, although it still faces significant risks related to its financial status and potential delisting [1][2] Group 1: Company Overview - *ST Zhengping, officially known as Zhengping Road and Bridge Construction Co., Ltd., is engaged in infrastructure construction, cultural tourism, and non-ferrous metal mining [2] - The company provides services including infrastructure investment consulting, design and construction, operational management, cultural tourism, and mineral resource exploration and development [2] Group 2: Financial Performance - In 2024, *ST Zhengping reported revenue of 1.362 billion yuan and a net loss attributable to shareholders of 484 million yuan [2] - For the first three quarters of 2025, the company achieved revenue of 652 million yuan, a year-on-year decrease of 20.92%, with a net loss attributable to shareholders of approximately 99.76 million yuan [2] Group 3: Stock Performance and Risks - Since September, *ST Zhengping's stock has experienced 26 consecutive trading days of price increases, with a total rise of 221.93% from September 1 to November 18, significantly deviating from the Shanghai Composite Index and the construction industry [1] - The rapid increase in stock price has led to heightened trading risks, prompting the company to suspend trading for review on November 19, 2025 [1]

Core Viewpoint - The company announced that its stock will resume trading on December 3, 2025, after completing a recent review of stock trading activities [1] Group 1: Stock Trading and Market Conditions - The company's price-to-earnings (P/E) ratio and price-to-book (P/B) ratio are significantly higher than the industry average [1] - There is a relatively small external circulation of shares, which may lead to irrational speculation risks [1] Group 2: Control Change and Uncertainties - There is uncertainty regarding the change of control of the company, with questions surrounding the approval process and the timeline for approval [1]

Core Viewpoint - *ST Zhengping (603843) announced that its stock will resume trading on December 3 after completing a review of its trading situation, although it still faces significant uncertainties regarding its financial status and potential restructuring [1] Group 1: Stock Trading and Resumption - The company has completed the necessary review of its stock trading situation and has applied to the Shanghai Stock Exchange for resumption of trading [1] - The stock is set to resume trading on December 3 [1] Group 2: Financial Status and Audit Opinions - As of now, the company has not resolved the non-standard audit opinion for the fiscal year 2024 [1] - If the issues related to the non-standard opinion are not resolved by the fiscal year 2025, the company’s stock may face delisting [1] Group 3: Restructuring and Legal Proceedings - Recently, creditors have applied for the company’s pre-restructuring, but the company has not yet received any legal documents from the court regarding the acceptance of this application [1] - There is significant uncertainty regarding whether the court will accept the pre-restructuring application and whether the company will enter the restructuring process [1]

Core Viewpoint - TATA Health (01255) has resumed trading after more than 1.5 years, experiencing a significant price surge of over 500% in early trading, reaching HKD 1.86 with a trading volume of HKD 6.33 million [1] Summary by Relevant Sections - **Resumption of Trading** - TATA Health has successfully met all resumption guidelines, allowing it to resume trading after a prolonged suspension [1] - **Financial Performance and Compliance** - The company has published all outstanding financial results and addressed any audit revisions, ensuring compliance with regulatory requirements [1] - **Business Viability** - TATA Health confirmed that its business operations are sustainable, with sufficient operational capacity and valuable assets to support ongoing business activities [1] - **Internal Controls** - An independent internal control review has been conducted, demonstrating that the company has established adequate internal controls and procedures to fulfill its responsibilities under listing rules [1]

Group 1 - The company announced that its stock will resume trading on November 21, 2025, following the completion of relevant verification work [1] - The company's current rolling price-to-earnings ratio and price-to-book ratio show significant differences compared to industry peers [1] - The company's main business has not undergone significant changes, but there is a risk of market sentiment overheating and irrational speculation due to a recent continuous rise in stock price [1]

Core Viewpoint - The company, HeFu China, announced that its stock will resume trading on November 20, 2025, after a significant price increase during the trading suspension period [1] Summary by Relevant Sections Stock Performance - From October 28 to November 14, the company's stock experienced a remarkable performance, with 12 out of 14 trading days closing at the daily limit price, resulting in a total increase of 256.29%, significantly outperforming the industry and the Shanghai Composite Index [1] Financial Status - The company's main business remains unchanged; however, it is currently operating at a loss, with a net profit attributable to shareholders of -5.048 million yuan in the third quarter of 2025 [1] - The latest price-to-earnings (P/E) ratio stands at 343.67, which is considerably higher than that of peer companies in the industry [1] Investor Advisory - The company has advised investors to be aware of performance volatility and the risks associated with high valuation, urging rational investment and caution regarding trading risks [1]

Group 1 - The company announced a plan to issue A-shares to a specific entity, Dingyun Industry, with a maximum of 53,649,956 shares to be issued, raising up to 610 million yuan, which will be used to supplement working capital [1] - The issuance will result in a change of the company's controlling shareholder and actual controller, with Dingyun Industry becoming the new controlling shareholder and Mr. Li Hongxing as the new actual controller [1] - The company had no controlling shareholder or actual controller prior to this issuance [1] Group 2 - The company's stock will resume trading on November 19, 2025, following an application to the Shenzhen Stock Exchange [2] - For the first half of 2025, the company's revenue composition was 96.6% from communication equipment and system integration, with other businesses accounting for 3.4% [3] - As of the report date, the company's market capitalization was 2.9 billion yuan [4]

Core Viewpoint - The company, China Laiqi (08039), has received a letter from the Stock Exchange regarding the guidelines for the resumption of trading of its shares, which are currently suspended [1] Group 1: Resumption Guidelines - The company must publish all outstanding financial results as required by the GEM Listing Rules and address any audit modifications [1] - The company is required to demonstrate compliance with GEM Listing Rule 17.26 [1] - The company must communicate all significant information to the market for shareholders and investors to assess its condition [1] Group 2: Current Status - The company's shares remain suspended from trading [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不對因本公告全部或任何部分內容而產生或因 倚賴該等內容而引致之任何損失承擔任何責任。 CHINA COME RIDE NEW ENERGY GROUP LIMITED 中國來騎哦新能源集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：8039） 復牌指引、有關復牌狀況的季度最新資料及繼續暫停買賣 本公告乃由中國來騎哦新能源集團有限公司（「本公司」，連同其附屬公司， 統稱「本集團」）根據香港聯合交易所有限公司（「聯交所」）GEM證券上市規則 （「GEM上市規則」）第17.10(2)(a)條及香港法例第571章證券及期貨條例第XIVA部 的內幕消息條文（定義見GEM上市規則）而刊發。 茲提述本公司日期為二零二五年六月三十日、二零二五年八月一日、二零二五 年八月十八日、二零二五年八月二十八日、二零二五年九月十九日、二零二五 年十月十五日及二零二五年十一月七日的公告，內容有關（其中包括）延遲刊 發2025年度業績及本公司股份自二零二五年七月二日上午九時正起在聯交所暫 停買賣（「該等公告」 ...